<PAGE>

                     U.S. Securities and Exchange Commission

                             Washington, D.C. 20549

                                   Form 10-QSB

[X]  QUARTERLY  REPORT  PURSUANT  TO  SECTION  13 OR 15 (d)  OF  THE  SECURITIES
     EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2002

[_]  TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR 15 (d)  OF THE  SECURITIES
     EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File number:0-25429

                      Diversified Product Inspections, Inc.
                     ---------------------------------------
                     (Exact name of small business issuer as
                            specified in its charter)

          Florida                                              65-0832025
- ---------------------------------                    -----------------------
(State of other jurisdiction of                             (IRS Employer
incorporation or organization)                             Identification No.)


                                  3 Main Street
                               Oak Ridge, TN 37830
                  --------------------------------------------
                    (Address of principal executive offices)


                                 (865) 482-8480
                           ---------------------------
                           (Issuer's telephone number)


                                   February 28th
              -----------------------------------------------------
              (Former name, former address, and former fiscal year,
                          if changed since last report)

         Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15 (d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

                                            Yes _X_    No ___

         As of November 6, 2002, there were 14,961,457 shares of common stock,
$0.01 par value, issued and outstanding.

<PAGE>





                          Index to Financial Statements





Condensed  Consolidated  Balance Sheets                                      F-2
Condensed  Consolidated  Statements  of  Operations                          F-3
Condensed  Consolidated  Statements  of  Cash  Flows                         F-4
Notes  to  Condensed  Consolidated  Financial  Statements                    F-5







                                       F-1

<PAGE>
<TABLE>
<CAPTION>


                         PART I - FINANCIAL INFORMATION

ITEM  1.   FINANCIAL  STATEMENTS


                      Diversified Product Inspections, Inc.
                      Condensed Consolidated Balance Sheets


<S>                                                      <C>               <C>
                                                     September  30     December  31
                                                          2002             2001
                                                    ---------------- ---------------
                                                       (Unaudited)
Assets
Current  assets:
 Cash                                                  $   61,941     $  46,016
 Accounts  receivable,  net                               223,340       104,841
 Refundable  income  taxes                                  5,214         5,214
 Prepaid  expenses  and  other  current  assets             4,453         2,323
                                                    ---------------- ---------------
Total  current  assets                                    294,948       158,394

Property  and  equipment:
 Equipment,  furniture  and  fixtures                     173,655       173,655
 Vehicles                                                  97,737        97,737
 Leasehold  improvements                                   22,727        22,727
                                                    ---------------- ---------------
                                                           294,119      294,119
 Less  accumulated  depreciation  and  amortization        171,440      119,359
                                                    ---------------- ---------------
Net  property  and  equipment                              122,679      174,760

Other  assets                                                4,400        4,400
                                                    ---------------- ---------------
Total  assets                                          $   422,027    $ 337,554
                                                    ================ ===============

Liabilities  and  stockholders'  deficit
Current  liabilities:
 Lines  of  credit                                     $    89,044    $ 123,929
 Accounts  payable  and  accrued  expenses                 206,797      139,567
 Accrued  salaries                                          13,816       13,816
 Advance  from  stockholder                                 16,000       18,000
 Current  portion  of  long-term  debt                      15,794       16,517
 Current  portion  of  capital  lease  obligations           3,935       14,545
                                                    ---------------- ---------------
Total  current  liabilities                                345,386      326,374

Long-term  debt,  less  current  portion                    27,950       38,758
Convertible  debt,  net  of  discount  of $3,332           196,668           --
                                                    ---------------- ---------------
Total  liabilities                                         570,004      365,132

Stockholders'  deficit:
 Common  stock,  par  value  $0.01,  authorized
 50,000,000  shares,  issued  and
 outstanding  14,961,457 in 2002 and 14,255,709 in 2001   149,614       142,558
 Additional  paid-in  capital                           1,604,911     1,390,037
 Accumulated  deficit                                  (1,759,109)   (1,560,173)
 Deferred  stock  issuance  costs                        (143,393)            -
                                                    ---------------- ---------------
Total  stockholders'  deficit                            (147,977)      (27,578)
                                                    ---------------- ---------------
Total  liabilities  and  stockholders'  deficit        $  422,027     $ 337,554
                                                    ================ ===============

</TABLE>
     See accompanying Notes to Condensed Consolidated Financial Statements.
                                      F-2

<PAGE>
                      Diversified Product Inspections, Inc.
          Condensed Consolidated Statements of Operations (Unaudited)


<TABLE>
<CAPTION>
                                 Three  Months  Ended     Nine  Months  Ended
                                    September  30             September  30
                                 2002           2001     2002              2001
                               -----------------------  --------------------------
<S>                             <C>            <C>         <C>            <C>
Revenues                    $  512,667     $  335,995     $1,402,929    $  821,018

Operating  expenses:
 Salaries                      260,447        185,535        700,935       501,755
 Depreciation                   17,360         17,101         52,081        48,411
 General  and administrative   236,219        200,835        771,930       584,006
                               -----------------------  --------------------------
Total  operating  expenses     514,026        403,471      1,524,946     1,134,172
                               -----------------------  --------------------------


Operating  loss                 (1,359)        (67,476)     (122,017)     (313,154)

Other  income  (expense):
 Other  income                       -          1,348             -        10,953
 Other  expense                      -         (1,155)            -        (3,709)
 Interest  expense              (5,630)        (6,852)       (76,919)     (19,923)
                               -----------------------  --------------------------
Net  other  expense             (5,630)        (6,659)       (76,919)     (12,679)
                               -----------------------  --------------------------
Net  loss                      $(6,989)     $ (74,135)     $(198,936)   $(325,833)
                               =======================  ==========================
Loss  per  common  share        $(0.01)     $   (0.01)     $   (0.01)   $   (0.02)
                               =======================  ==========================
</TABLE>
     See accompanying Notes to Condensed Consolidated Financial Statements.
                                      F-3
<PAGE>

                      Diversified Product Inspections, Inc.
          Condensed Consolidated Statements of Cash Flows (Unaudited)


<TABLE>
<CAPTION>
                                                            Nine  months  ended
                                                               September  30
                                                              2002        2001
                                                       ----------------------------
<S>                                                          <C>           <C>
Operating  activities
Net  loss                                               $(198,936)     $(325,833)
Adjustments  to  reconcile  net  loss  to  net  cash
 used  in  operating  activities:
  Depreciation  and  amortization                          52,081         48,411
  Interest  expense  on  convertible debt
   issued at a conversion rate below market value          50,205              -
 Changes  in  operating  assets  and  liabilities:
  Accounts  receivable                                   (118,499)       (30,167)
  Prepaid  expenses  and  other  assets                    (2,130)         3,450
  Accounts  payable  and  accrued  expenses                67,230         89,880
  Accrued  salaries                                             -          2,461
  Other  current  liabilities                                   -         (4,634)
                                                       ----------------------------
Net  cash  used  in  operating  activities               (150,049)      (216,432)

Investing  activities
Purchases  of  property  and  equipment                         -        (62,039)

Financing  activities
Payment  on  shareholder  advance                          (2,000)             -
Net  payments  on  line  of  credit                       (34,885)             -
Proceeds  from  convertible  debt                         200,000              -
Principal  payments  of  long-term  debt
  and  capital  lease  obligation                         (22,141)       (22,328)
Proceeds  from  sale  of  common  stock                    25,000        200,000
                                                       ----------------------------
Net  cash  provided  by  financing  activities            165,974        177,672
                                                       ----------------------------

Net  increase  (decrease)  in  cash                        15,925       (100,799)

Cash  at  beginning  of  period                            46,016        154,573
                                                       ----------------------------
Cash  at  end  of  period                              $   61,941      $  53,774
                                                       ============================

Supplemental  disclosure  of  cash  flow  information

Cash  paid  for  interest  during  the  period         $   26,714     $   19,923
                                                       ============================
</TABLE>
     See accompanying Notes to Condensed Consolidated Financial Statements.
                                      F-4

<PAGE>

                      Diversified Product Inspections, Inc.

NOTES  TO  CONDENSED  CONSOLIDATED  FINANCIAL  STATEMENTS  (UNAUDITED)

1.  BASIS  OF  PRESENTATION

The  accompanying  unaudited  condensed  consolidated  financial  statements  of
Diversified  Products  Inspections,  Inc.  (the "Company") have been prepared in
accordance with accounting principles generally accepted in the United States of
America  for  interim  financial  information  and  pursuant  to  the  rules and
regulations  of  the  Securities and Exchange Commission.   Accordingly, they do
not  include  all  of  the  information  and  footnotes  required  by accounting
principles  generally  accepted  in  the  United  States of America for complete
financial statements.  In the opinion of management, all adjustments (consisting
of  normal recurring accruals) considered necessary for a fair presentation have
been  included.  Operating  results  for the three- and nine-month periods ended
September  30,  2002  are  not necessarily indicative of the results that may be
expected  for  the  year  ended  December  31,  2002.

The  condensed  consolidated  financial  statements  include  the  accounts  of
Diversified  Product  Inspections,  Inc.  and  its  wholly  owned  subsidiary,
Diversified  Product Investigations, Inc. ("Investigations").  All inter-company
balances  and  transactions  have  been  eliminated.

The  balance  sheet  at  December  31,  2001  has  been derived from the audited
financial  statements  at  that date but does not include all of the information
and  formats  required by accounting principles generally accepted in the United
States  of  America  for  complete  financial  statements.

For  further  information,  refer  to  the consolidated financial statements and
footnotes thereto included in the Company's annual report on Form 10-KSB for the
year  ended  February  28,  2002.

2.     CHANGE  IN  FISCAL  YEAR-END

Effective  June  26,  2002,  Diversified  Product  Inspections, Inc., the parent
holding  company,  changed  its fiscal year-end from the last day in February to
December  31  to  correspond  with  the  fiscal  year-end of Investigations, its
subsidiary  operating  company.  Accordingly, these interim financial statements
reflect  the  change  in  fiscal  year-end.

3.     COMPANY  STOCK  TRANSACTIONS

During  January  2002,  the Company received $25,000 for 71,429 shares of common
stock.

The  Company has outstanding stock warrants to a stockholder which allow for the
purchase of 375,000 shares of the Company's stock at an exercise price of $1 per
share.

As  discussed  in Note 4, the Company issued 387,097 shares of common stock to a
company  as  a  commitment  fee  related  to an equity line of credit agreement.
Additionally,  the  Company  issued  247,222  shares  of common stock to certain
attorneys  for  fees  associated  with this agreement.  As these represent costs
associated  with  raising  capital,  the Company has presented the $143,393 as a
reduction  of  equity  pending  future  funding  under  this  agreement.


                                       F-5

<PAGE>
                      Diversified Product Inspections, Inc.

NOTES  TO  CONDENSED  CONSOLIDATED  FINANCIAL STATEMENTS (CONTINUED) (UNAUDITED)

4.     CONVERTIBLE  DEBT  AND  EQUITY  LINE  OF  CREDIT  AGREEMENT

During  April  2002,  the  Company  entered into a subscription agreement with a
company  (the  "Investor")  in which the Company will receive up to $300,000 (in
$100,000  tranches)  from  the  Investor in return for a corresponding amount of
convertible debentures and related warrants.  Significant terms of the agreement
are  summarized  as  follows:

-     The  debentures may be converted at any time by the Investor at the lesser
of  (i) 110% of the average five closing bid prices during the five trading days
prior to the issuance date or (ii) 75% of the average of the five lowest closing
bid  prices  during  the twenty trading days immediately prior to the conversion
date.
-     In  the  event all or any portion of the debentures are outstanding at the
end  of  three  years  from  the date of issuance, the debentures are subject to
automatic conversion into Company stock based upon the conversion rate described
above.

-     The debentures shall pay 6% cumulative interest, payable in arrears at the
time  of  each  conversion,  in  cash  or  common  stock  of the Company, at the
Company's  option.

-     The  debentures  are  secured  by 4,000,000 shares of the Company's common
stock,  which  is  currently  owned  by  the  Company's  majority  stockholders.

-     Upon  funding  of  the  first  tranche, the Company issued to the Investor
warrants  to purchase the resulting number of shares of the Company's stock that
equals the total amount being funded in all three tranches, divided by the share
price  (five day average closing bid price prior to closing).  The warrants will
be  exercisable  for  four  years  from  the  corresponding closing date of that
tranche  being funded, at 110% of the five day average closing bid price for the
five  trading  days  prior  to the closing date of each funding tranche and will
carry  a  cashless  provision  only  at  the  option  of  the  Company.

During  April  2002,  the  Company received its first $100,000 tranche under the
terms  of  the  agreement.  As  a result of the conversion rates described above
which  allow for the conversion at a price less than the stock price at the date
of  the  funding,  and in accordance with provisions of the Financial Accounting
Standards  Board  Emerging  Issues  Task  Force  Issue  No.  98-5 ("EITF 98-5"),
Accounting  for  Convertible  Securities  with Beneficial Conversion Features or
Contingently  Adjustable  Conversion  Rates,  the  Company  recognized  interest
expense  and  increased  additional  paid-in capital by $27,250 related to these
debentures  at  the date of funding.  Additionally, in accordance with the terms
of the agreement described above, the Company issued warrants to the Investor to
purchase  an additional 462,963 shares of stock at an exercise price of $0.2376.
The Company estimated the value of these warrants to be $1,666 and, accordingly,
the  $100,000 convertible debt was discounted and additional paid-in capital was
increased  by  this  amount.

During  June  2002,  the  Company received its second $100,000 tranche under the
terms  of  the  agreement.  As  a result of the conversion rates described above
which  allow for the conversion at a price less than the stock price at the date
of  the  funding,  and  in  accordance with provisions of EITF 98-5, the Company
recognized  interest expense and increased additional paid-in capital by $22,955
related to these debentures at the date of funding.  Additionally, in accordance
with  the terms of the agreement described above, the Company issued warrants to
the  Investor  to  purchase an additional 462,963 shares of stock at an exercise
price of  $0.23.  The Company estimated the value of these warrants to be $1,666
and,  accordingly,  the  $100,000 convertible debt was discounted and additional
paid-in  capital  was  increased  by  this  amount.

                                       F-6

<PAGE>
                      Diversified Product Inspections, Inc.

NOTES  TO  CONDENSED  CONSOLIDATED  FINANCIAL STATEMENTS (CONTINUED) (UNAUDITED)


4.  CONVERTIBLE  DEBT  AND  EQUITY  LINE  OF  CREDIT  AGREEMENT  (CONTINUED)

During  October  2002, the Company received its third $100,000 tranche under the
terms  of  the  agreement.  As  a result of the conversion rates described above
which  allow for the conversion at a price less than the stock price at the date
of  the  funding,  and  in  accordance with provisions of EITF 98-5, the Company
recognized  interest expense and increased additional paid-in capital by $13,750
related to these debentures at the date of funding.  Additionally, in accordance
with  the terms of the agreement described above, the Company issued warrants to
the  Investor  to  purchase an additional 462,963 shares of stock at an exercise
price of $0.088.  The Company estimated the value of these warrants to be $1,668
and,  accordingly,  the  $100,000 convertible debt was discounted and additional
paid-in  capital  was  increased  by  this  amount.

Also  during  April  2002,  the  Company  entered  into an equity line of credit
investment  agreement  with  the  Investor  which  provides  for the sale of the
Company's stock.  The Company's registration statement was declared effective in
October 2002 and subject to it remaining effective along with the fulfillment of
certain  other  terms and conditions contained in the agreement, the Investor is
obligated  to purchase up to $3,000,000 of the Company's common stock at a price
of  85%  of  the  average of the four lowest closing bid prices of the Company's
common  stock  during  the  ten  days  subsequent to the date of the put notice.
These  purchases will be made via put notices issued at the Company's discretion
and  each  single  put  notice  shall  not  be  less  than $15,000 nor more than
$150,000.  Under the terms of the equity line of credit investment agreement the
Company  has agreed to issue 387,097 shares of the Company's common stock to the
Investor  as a commitment fee.  Additionally, under the terms of the equity line
of  credit  investment  agreement,  the  Company  issued  warrants  enabling the
Investor  to purchase 1,388,889 at an exercise price of $0.2376 per share, which
is  above  the  trading value of the stock at the date the warrants were issued.
These  warrants  expire  in  April  2006.  As  of  October 29, 2002, no such put
notices have been made by the Company and, accordingly, no stock has been issued
under  the  terms  of  the  equity  line  of  credit.

5.     COMMITMENTS  AND  CONTINGENCIES

The  Company  currently  leases  its  office  and  warehouse  under an agreement
classified  as  an operating lease.  Under the terms of the lease agreement, the
Company  is  obligated  to  purchase  the  office  and  warehouse if the Company
receives $3,000,000 in proceeds from a private placement offering.  The purchase
price  will  range from between $1,500,750 and $1,607,640, depending on the year
the  purchase  takes  place.  This  purchase  obligation expires on December 31,
2004.

6.     LOSS  PER  SHARE  DATA

Basic  loss  per  share  assumes  no  dilution  and is computed by dividing loss
available  to common stockholders by the weighted average number of common stock
outstanding  during each period.  Diluted earnings per share reflect, in periods
in  which they have a dilutive effect, the effect of common shares issuable upon
the  exercise  of  stock  warrants, using the treasury stock method of computing
such  effects  and  contingent  shares, or conversion of convertible debt.  As a
result of the Company's losses, the effect of the outstanding stock warrants and
convertible  debt  has  an  antidilutive effect and there is no diluted loss per
share.
                                       F-7

<PAGE>
                      Diversified Product Inspections, Inc.

NOTES  TO  CONDENSED  CONSOLIDATED  FINANCIAL STATEMENTS (CONTINUED) (UNAUDITED)



6.     LOSS  PER  SHARE  DATA  (CONTINUED)

The  following  table sets forth the computation of basic loss per share for the
periods  indicated:

<TABLE>
<CAPTION>
<S>                                            <C>                                 <C>
                                         THREE MONTHS ENDED                   NINE MONTHS ENDED
                                            SEPTEMBER 30                         SEPTEMBER 30
                                        2002              2001              2002                2001
                             ------------------  ------------------ -----------------  ----------------
Net loss                       $       (6,989)     $     ( 74,135)    $    (198,936)     $   (325,833)
Average  shares  outstanding       14,955,207          14,125,357        14,693,087        13,997,854
                             ------------------  ------------------ -----------------  ----------------
Basic  loss  per  share        $        (0.01)     $        (0.01)    $       (0.01)     $      (0.02)
                             ==================  ================== =================  ================


</TABLE>

7.     GOING  CONCERN

The  accompanying  financial  statements  have  been prepared on a going concern
basis,  which  contemplates  the  realization  of assets and the satisfaction of
liabilities  in the normal course of business.  The Company's continuing losses,
among  other  things,  may  indicate the Company will be unable to continue as a
going  concern  for  a  reasonable  period  of  time.  Management recognizes the
Company  must  return  to profitable operations and generate additional funds in
order  to  continue as a going concern.  The Company has previously successfully
raised  capital  to  fund  its  operations  and  the  Company  has  arranged for
additional  capital  as  discussed  in  Note  4.



                                       F-8
<PAGE>

Item 2. Management's Discussion and Analysis of Results of Operations

Introduction

     This Quarterly Report on Form 10-QSB should be read in conjunction with our
unaudited financial statements included as part of this Form 10-QSB Report. This
report  contains  forward-looking  statements  which are  described  and defined
below.

General

We  specialize  in  conducting  investigations and laboratory analysis of a wide
variety  of  products to determine the cause and origin of product failures. Our
primary customers consist of national insurance companies that are interested in
subrogating  claims  to  recover losses. Subrogation is a legal principle, which
provides  that,  to  the  extent  an  insurer  has  paid for a loss, the insurer
receives  the  policyholder's  right to recover from any third party that caused
the  loss. We have accumulated a large database of known defective products that
includes  photos  and other documentation that are used in their investigations.
Additionally,  we  provide  for the storage of evidence and derive revenues from
the  secure  storage  of  materials.

On  June  26, 2002, we changed our fiscal year end from the last day in February
to  December 31. We changed our fiscal year to conform to the fiscal year of our
subsidiary,  Diversified  Product  Investigations,  Inc.


Results of Operations  for the Nine Month Period Ended September 30, 2002

Overview

The  Company had net losses of $(6,989) for the three months ended September 30,
2002  and had net losses of $(198,936) for the nine month period ended September
30, 2002 as compared to $(325,833) for the nine month period ended September 30,
2001.  Since  acquiring the shares of Investigations, the company has focused on
conducting  investigations and laboratory analysis of a wide variety of products
to  determine  the  "cause  and  origin"  of  product  failures.
<PAGE>
Financial Position

As of September 30, 2002, the Company had cash available of $61,941 an increase
of  $46,016  from  December  31,  2001.  This  increase is primarily due to the
injection  of  private  placement  funds  from  the sale of our common stock and
proceeds  of  convertible  debt.

Revenues

For  the  nine  months  ended September 30, 2002 and 2001, the Company had total
revenues  of  $1,402,929  and  $821,018 respectively. For the three months ended
September  30,  2002  and  2001,  the Company had total revenues of $512,667 and
$335,995  respectively.  Substantially  all  revenues  were  derived  from
investigations and laboratory analysis work related to determining the cause and
origin  of  product failures. Management attributes this increase in revenues to
our  marketing  efforts.

Selling, General, and Administrative Expenses

For the three month period ended September 30, 2002, total operating expenses
increased by $110,555 from $403,471 for the three month period ended September
30, 2001. This fluctuation is attributed primarily to an increase in salaries
expense of $74,912 due to additional staffing as well as an increase of
$35,384 in general and administrative costs.

Liquidity and Capital Resources

The  financial  condition, liquidity and capital resources of the Company should
be  assessed  in  context with the ability of the Company to continue as a going
concern  as  discussed  in  the independent auditors' report for the fiscal year
ended December 31, 2001.

The  Company's  operations  have  been funded primarily from the issuance of its
Common  Stock  for  cash and proceeds from convertible debt.  This  allowed the
Company to continue its operations.

The  Company  anticipates  that  revenues will continue to be generated from the
investigative and analysis services it provides and that such revenues will help
to  fund the current level of operations. Provided that revenues continue and/or
additional funding is secured, the Company believes that it can meet its capital
needs  through  the  balance  of  the  current  calendar  year.  There can be no
assurance  that  the  Company  will  be  successful  in  these  efforts.

<PAGE>

We are not aware of any material trend, event or capital commitment, which would
potentially  adversely affect our liquidity. In the event such a trend develops,
we  believe  that  we  will  have  sufficient funds available to satisfy working
capital  needs through lines of credit and the funds expected from equity sales.

Forward-Looking Statements

     This Form 10-QSB includes  "forward-looking  statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities  Exchange  Act of  1934,  as  amended.  All  statements,  other  than
statements of historical  facts,  included or  incorporated by reference in this
Form 10-QSB which address  activities,  events or developments which the Company
expects or anticipates will or may occur in the future, including such things as
future capital expenditures  (including the amount and nature thereof),  finding
suitable merger or acquisition candidates, expansion and growth of the Company's
business  and operations, and other such matters are forward-looking statements.
These  statements  are  based  on  certain  assumptions and analyses made by the
Company  in  light  of  its  experience and its perception of historical trends,
current  conditions and expected future developments as well as other factors it
believes  are  appropriate in the circumstances. However, whether actual results
or  developments will conform with the Company's expectations and predictions is
subject  to  a  number  of  risks and uncertainties, general economic market and
business  conditions;  the  business opportunities (or lack thereof) that may be
presented  to  and  pursued  by  the Company; changes in laws or regulation; and
other  factors,  most  of  which  are  beyond  the  control  of  the  Company.
Consequently, all of the forward-looking statements made in this Form 10-QSB are
qualified  by these cautionary statements and there can be no assurance that the
actual  results  or developments anticipated by the Company will be realized or,
even  if substantially realized, that they will have the expected consequence to
or  effects on the Company or its business or operations. The Company assumes no
obligations  to  update  any  such  forward-looking  statements.

Item 3.  Controls  And  Procedures

Management  continuously  evaluates  our  internal  controls  and procedures and
believes  that such controls and procedures are effective. There were no changes
in  the  Company's  internal  controls  or  in  other  factors  that  could have
significantly  affected  those  controls subsequent to the date of the Company's
most  recent  evaluation.

<PAGE>
                                     PART II



Item 1. Legal Proceedings.

The Company knows of no legal proceedings to which it is a party or to which any
of  its property is the subject which are pending, threatened or contemplated or
any  unsatisfied  judgments  against  the  Company.


Item 2. Changes in Securities

No  shares  of  the Company's common stock were issued by the Company during the
three  month  period  ended  September  30,  2002.

Item 3. Defaults in Senior Securities

         None

Item 4. Submission of Matters to a Vote of Security Holders.

         None.

<PAGE>

Item 5. Other Information

During  April  2002,  the  Company  entered into a subscription agreement with a
company  (the "Investor") in which the Company was to receive up to $300,000 (in
$100,000  tranches)  from  the  Investor in return for a corresponding amount of
convertible  debentures and related warrants. Significant terms of the agreement
are  summarized  as  follows:

-     The  debentures may be converted at any time by the Investor at the lesser
of  (i) 110% of the average five closing bid prices during the five trading days
prior to the issuance date or (ii) 75% of the average of the five lowest closing
bid  prices  during  the twenty trading days immediately prior to the conversion
date.
-     In  the  event all or any portion of the debentures are outstanding at the
end  of  three  years  from  the date of issuance, the debentures are subject to
automatic conversion into Company stock based upon the conversion rate described
above.

-     The debentures shall pay 6% cumulative interest, payable in arrears at the
time  of  each  conversion,  in  cash  or  common  stock  of the Company, at the
Company's  option.

-     The  debentures  are  secured  by 4,000,000 shares of the Company's common
stock,  which  is  currently  owned  by  the  Company's  majority  stockholders.

In  October  2002,  the Company's Registration Statement on Form SB-2 related to
the  shares  underlying the convertible debentures and the Company's equity line
of  credit  was  declared  effective  by the Securities and Exchange Commission.
Subsequently,  in  October 2002, the Company received its third $100,000 tranche
From  the  sale  of  the  Company's convertible debenture under the terms of its
investment  agreement.  Additionally,  in  accordance  with  the  terms  of  the
agreement  described  above,  the  Company  issued  warrants  to the Investor to
purchase  an  additional 462,963 shares of the Company's common stock at an
exercise price of $0.088.

Item 6. Exhibits and Reports on Form 8-K

(a)  Exhibits

(b)  The Company did not file a Report on Form 8-K  for the third quarter ended
     September 30, 2002.



<PAGE>

                                   SIGNATURES


     In accordance  with the  requirements  of the Exchange Act, the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                      Diversified Product Inspections, Inc.
                                  (Registrant)


Date: November 7, 2002     /s/ John Van Zyll
                           ------------------------------------------
                           John Van Zyll
                           President, Chief Executive Officer and Chairman
                           (Principal Executive Officer and
                            Principal Accounting Officer)
<PAGE>

                           CERTIFICATIONS PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Quarterly Report of Diversified Product Inspections, Inc.
(the  "Company")  on  Form  10-QSB  for the period ending September 30, 2002, as
filed  with  the  Securities  and  Exchange  Commission  on the date hereof (the
"Report"),  the undersigned, Chief Executive Officer and Chief Financial Officer
of  the  Company,  certifies,  pursuant  to  18  U.S.C. Section 1350, as adopted
pursuant  to  Section  906  of  the  Sarbanes-Oxley  Act  of  2002,  that:

(1)  The Report fully complies with the requirements of section 3(a) or 15(d) of
     the  Securities  and  Exchange  Act  of  1934;  and

(2)  The  information  contained  in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.



                         /s/ John Van-Zyll
                         ______________________________________
                         By: John Van-Zyll
                         Chief Executive Officer/Chief Financial Officer
                         November 7, 2002


<PAGE>

                            CERTIFICATION PURSUANT TO
                            -------------------------
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
                  ---------------------------------------------

     I,  John Van-Zyll,  certify  that:

     1.     I  have  reviewed  this  quarterly report on Form 10-QSB of
Diversified Product Inspections,  Inc.

     2.     Based  on  my  knowledge, this quarterly report does not contain any
untrue  statement  of a material fact or omit to state a material fact necessary
to  make  the  statements  made,  in light of the circumstances under which such
statements  were made, not misleading with respect to the period covered by this
quarterly  report;

     3.     Based on my knowledge, the financial statements, and other financial
information  included  in  this quarterly report, fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods presented in this quarterly report;

     4.     The registrant's other certifying officers and I are responsible for
establishing  and  maintaining disclosure controls and procedures (as defined in
Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  we  have:

     a) designed such disclosure controls and procedures to ensure that material
information  relating  to  the  registrant, is made known to us by others within
those entities, particularly during the period in which this quarterly report is
being  prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls and
procedures  as  of  a  date  within  90  days  prior  to the filing date of this
quarterly  report  (the  "Evaluation  Date");  and

     c)  presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness  of the disclosure controls and procedures based on our evaluation
as  of  the  Evaluation  Date;

     5.     The  registrant's  other  certifying  officers and I have disclosed,
based  on our most recent evaluation, to the registrant's auditors and the audit
committee  of  registrant's  board  of  directors  (or  persons  performing  the
equivalent  function):

     a)  all  significant  deficiencies  in  the design or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and

     b)  any  fraud,  whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

     6.     The  registrant's  other certifying officers and I have indicated in
this  quarterly report whether or not there were significant changes in internal
controls  or  in other factors that could significantly affect internal controls
subsequent  to  the date of our most recent evaluation, including any corrective
actions  with  regard  to  significant  deficiencies  and  material  weaknesses.

Date:  November  7,  2002



                         /s/ John Van-Zyll
                         ______________________________________
                         By: John Van-Zyll
                         Chief Executive Officer/Chief Financial Officer




<PAGE>